GNMK Share Price

Open 12.65 Change Price %
High 12.75 1 Day 0.04 0.32
Low 12.36 1 Week 0.03 0.24
Close 12.65 1 Month 0.66 5.50
Volume 124579 1 Year 5.86 86.30
52 Week High 13.43
52 Week Low 4.20
GNMK Important Levels
Resistance 2 13.01
Resistance 1 12.86
Pivot 12.59
Support 1 12.44
Support 2 12.29
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
APRI 2.86 89.40%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
APRI 2.86 89.40%
AMCF 0.06 50.00%
LOCM 0.09 50.00%
SKBI 0.12 50.00%
UNXL 1.69 34.13%
LIFE 3.25 32.65%
CHCI 2.42 29.41%
GLBS 6.17 27.22%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
THTI 0.15 -40.00%
More..

GenMark Diagnostics, Inc. (NASDAQ: GNMK)

GNMK Technical Analysis 5
As on 18th Jan 2017 GNMK Share Price closed @ 12.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.99 & Strong Buy for SHORT-TERM with Stoploss of 11.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
GNMK Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
GNMK Other Details
Segment EQ
Market Capital 273291424.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.genmarkdx.com
GNMK Address
GNMK
5964 La Place Court
Carlsbad, CA 92008
United States
Phone: 760-448-4300
Fax: 760-448-4301
Interactive Technical Analysis Chart GenMark Diagnostics, Inc. ( GNMK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GenMark Diagnostics, Inc.
GNMK Business Profile
GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company�s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA), and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its eSensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.